Antti Tanskanen

Publications
CV
Public outreach and news

Articles

Article: SCANDINAVIAN JOURNAL OF PUBLIC HEALTH. 2023;51(8):1222-1230

Use of benzodiazepine and related drugs in migrants and Finnish-born persons: a nationwide register-based study.

Lehti V; Salama E; Niemelä S; Tanskanen A; Gissler M; Suvisaari J; Taipale H
Article: JOURNAL OF AFFECTIVE DISORDERS. 2023;333:403-408

Non-adherence to mood stabilizers and antipsychotics among persons with bipolar disorder - A nationwide cohort study.

Lintunen J; Lähteenvuo M; Tanskanen A; Tiihonen J; Taipale H
Article: ACTA PSYCHIATRICA SCANDINAVICA. 2023;147(6):603-613

Association of pharmacological treatments and real-world outcomes in borderline personality disorder.

Lieslehto J; Tiihonen J; Lähteenvuo M; Mittendorfer-Rutz E; Tanskanen A; Taipale H
Article: AMERICAN JOURNAL OF PSYCHIATRY. 2023;180(5):377-385

Safety of Antipsychotic Polypharmacy Versus Monotherapy in a Nationwide Cohort of 61,889 Patients With Schizophrenia.

Taipale H; Tanskanen A; Tiihonen J
Article: BJPSYCH OPEN. 2023;9(3):e57

Antipsychotic treatment patterns in refugees and their Swedish-born peers with first-episode non-affective psychosis: findings from the REMAIN study.

Spaton Goppers J; Mittendorfer-Rutz E; Cullen AE; Jamil de Montgomery C; Tanskanen A; Norredam M; Taipale H
Article: ACTA PSYCHIATRICA SCANDINAVICA. 2023;147(3):257-266

Real-world effectiveness of mood stabilizer use in schizophrenia.

Puranen A; Koponen M; Lähteenvuo M; Tanskanen A; Tiihonen J; Taipale H
Article: PSYCHOLOGICAL MEDICINE. 2023;53(4):1224-1232

Labour market marginalisation in young adults diagnosed with attention-deficit hyperactivity disorder (ADHD): a population-based longitudinal cohort study in Sweden.

Helgesson M; Björkenstam E; Rahman S; Gustafsson K; Taipale H; Tanskanen A; Ekselius L; Mittendorfer-Rutz E
Article: BJPSYCH OPEN. 2023;9(2):e40

Patient factors associated with receipt of psychological and pharmacological treatments among individuals with common mental disorders in a Swedish primary care setting.

Cullen AE; Lindsäter E; Rahman S; Taipale H; Tanskanen A; Mittendorfer-Rutz E; Helgesson M
Article: JOURNAL OF ALZHEIMERS DISEASE. 2023;91(4):1283-1290

The Cumulative Use of Muscle Relaxants and the Risk of Alzheimer's Disease: A Nationwide Case-Control Study.

Rahkonen A; Taipale H; Koponen M; Hartikainen S; Tolppanen A-M; Tanskanen A; Tiihonen M
Article: PSYCHOLOGICAL MEDICINE. 2023;53(3):833-843

Continuity of antipsychotic medication use among migrant and Finnish-born populations with a psychotic disorder: a register-based study.

Lehti V; Taipale H; Gissler M; Tanskanen A; Elonheimo M; Tiihonen J; Suvisaari J
Article: JOURNAL OF AFFECTIVE DISORDERS. 2023;321:28-32

Psychotic depression and deaths due to suicide.

Paljärvi T; Tiihonen J; Lähteenvuo M; Tanskanen A; Fazel S; Taipale H
Article: SCHIZOPHRENIA BULLETIN. 2023;49(1):136-143

Women with Schizophrenia-Spectrum Disorders After Menopause: A Vulnerable Group for Relapse.

Sommer IE; Brand BA; Gangadin S; Tanskanen A; Tiihonen J; Taipale H
Article: SCHIZOPHRENIA BULLETIN. 2023;49(1):78-89

Antipsychotic Use and Risk of Low-Energy Fractures in People With Schizophrenia: A Nationwide Nested Case-Control Study in Finland.

Solmi M; Lähteenvuo M; Correll CU; Tanskanen A; Tiihonen J; Taipale H
Article: BRITISH JOURNAL OF PSYCHIATRY. 2023;222(1):37-43

Mortality in psychotic depression: 18-year follow-up study.

Paljärvi T; Tiihonen J; Lähteenvuo M; Tanskanen A; Fazel S; Taipale H
Article: JAMA PSYCHIATRY. 2023;80(1):31-39

Association of Pharmacological Treatments and Hospitalization and Death in Individuals With Amphetamine Use Disorders in a Swedish Nationwide Cohort of 13 965 Patients.

Hartikainen M; Taipale H; Tanskanen A; Mittendorfer-Rutz E; Lähteenvuo M; Tiihonen J
Article: ACTA PSYCHIATRICA SCANDINAVICA. 2022;146(6):583-593

Twenty-year medication use trends in first-episode bipolar disorder.

Poranen J; Koistinaho A; Tanskanen A; Tiihonen J; Taipale H; Lähteenvuo M
Article: BRITISH JOURNAL OF PSYCHIATRY. 2022;221(6):758-765

Associations between antipsychotic use, substance use and relapse risk in patients with schizophrenia: real-world evidence from two national cohorts.

Lähteenvuo M; Luykx JJ; Taipale H; Mittendorfer-Rutz E; Tanskanen A; Batalla A; Tiihonen J
Article: AMERICAN JOURNAL OF PSYCHIATRY. 2022;179(12):938-946

Effectiveness of Antipsychotic Use for Reducing Risk of Work Disability: Results From a Within-Subject Analysis of a Swedish National Cohort of 21,551 Patients With First-Episode Nonaffective Psychosis.

Solmi M; Taipale H; Holm M; Tanskanen A; Mittendorfer-Rutz E; Correll CU; Tiihonen J
Article: JOURNAL OF AFFECTIVE DISORDERS. 2022;313:43-48

Allopurinol, dipyridamole and calcium channel blockers in the treatment of bipolar disorder - A nationwide cohort study.

Lintunen J; Lähteenvuo M; Tanskanen A; Tiihonen J; Taipale H
Article: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2022;61:36-42

Comparative effectiveness of mood stabilizers and antipsychotics in the prevention of hospitalization after lithium discontinuation in bipolar disorder.

Holm M; Tanskanen A; Lähteenvuo M; Tiihonen J; Taipale H
Article: BMC PSYCHIATRY. 2022;22(1):484

Healthcare utilization, costs, and productivity losses in treatment-resistant depression in Finland - a matched cohort study.

Taipale H; Lähteenvuo M; Tanskanen A; Huoponen S; Rannanpää S; Tiihonen J
Article: JOURNAL OF AFFECTIVE DISORDERS. 2022;308:236-242

Courses of treatment and risk factors for treatment-resistant depression in Finnish primary and special healthcare: A nationwide cohort study.

Lähteenvuo M; Taipale H; Tanskanen A; Rannanpää S; Tiihonen J
Article: SCHIZOPHRENIA BULLETIN. 2022;48(4):774-784

Optimal Doses of Specific Antipsychotics for Relapse Prevention in a Nationwide Cohort of Patients with Schizophrenia.

Taipale H; Tanskanen A; Luykx JJ; Solmi M; Leucht S; Correll CU; Tiihonen J
Article: INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH. 2022;19(12):7254

Occupational Branch and Labor Market Marginalization among Young Employees with Adult Onset of Attention Deficit Hyperactivity Disorder-A Population-Based Matched Cohort Study.

Gémes K; Björkenstam E; Rahman S; Gustafsson K; Taipale H; Tanskanen A; Ekselius L; Mittendorfer-Rutz E; Helgesson M
Article: ADDICTION. 2022;117(6):1683-1691

Real-world effectiveness of pharmacological treatments of opioid use disorder in a national cohort.

Heikkinen M; Taipale H; Tanskanen A; Mittendorfer-Rutz E; Lähteenvuo M; Tiihonen J
Article: JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION. 2022;23(6):1059-1065.e4

Antipsychotic Use and Risk of Stroke Among Community-Dwelling People With Alzheimer's Disease.

Koponen M; Rajamaki B; Lavikainen P; Bell JS; Taipale H; Tanskanen A; Hartikainen S; Tolppanen A-M
Article: BMC GERIATRICS. 2022;22(1):464

Prevalence of oral anticoagulant use among people with and without Alzheimer's disease.

Ali Babar B; Vu M; Koponen M; Taipale H; Tanskanen A; Kettunen R; Tiihonen M; Hartikainen S; Tolppanen A-M
Article: SCHIZOPHRENIA BULLETIN. 2022;48(3):655-663

Primary Nonadherence to Antipsychotic Treatment Among Persons with Schizophrenia.

Lieslehto J; Tiihonen J; Lähteenvuo M; Tanskanen A; Taipale H
Article: LANCET PSYCHIATRY. 2022;9(5):353-362

Long-term treatment with clozapine and other antipsychotic drugs and the risk of haematological malignancies in people with schizophrenia: a nationwide case-control and cohort study in Finland.

Tiihonen J; Tanskanen A; Bell JS; Dawson JL; Kataja V; Taipale H
Article: LANCET PSYCHIATRY. 2022;9(4):271-279

Real-world effectiveness of antipsychotic doses for relapse prevention in patients with first-episode schizophrenia in Finland: a nationwide, register-based cohort study.

Taipale H; Tanskanen A; Correll CU; Tiihonen J
Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2022;78(3):513-521

Automated multi-dose dispensing in persons with and without Alzheimer's disease-impacts on pharmacotherapy.

Vallius S; Taipale H; Koponen M; Tolppanen A-M; Tanskanen A; Hartikainen S; Tiihonen M
Article: JAMA PSYCHIATRY. 2022;79(3):210-218

Representation and Outcomes of Individuals With Schizophrenia Seen in Everyday Practice Who Are Ineligible for Randomized Clinical Trials.

Taipale H; Schneider-Thoma J; Pinzón-Espinosa J; Radua J; Efthimiou O; Vinkers CH; Mittendorfer-Rutz E; Cardoner N; Pintor L; Tanskanen A; Tomlinson A; Fusar-Poli P; Cipriani A; Vieta E; Leucht S; Tiihonen J; Luykx JJ
Article: JOURNAL OF ATTENTION DISORDERS. 2022;26(5):723-734

Risk Factors for Disability Pension among Young Adults Diagnosed with Attention-deficit Hyperactivity Disorder (ADHD) in Adulthood.

Chen L; Mittendorfer-Rutz E; Björkenstam E; Rahman S; Gustafsson K; Taipale H; Tanskanen A; Ekselius L; Helgesson M
Article: SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY. 2022;57(3):595-600

Maternal smoking during pregnancy and offspring psychiatric disorder: a longitudinal birth cohort study.

Brannigan R; Tanskanen A; Huttunen MO; Cannon M; Leacy FP; Clarke MC
Article: SCHIZOPHRENIA BULLETIN. 2022;48(1):166-175

Antipsychotics Use Is Associated With Greater Adherence to Cardiometabolic Medications in Patients With Schizophrenia: Results From a Nationwide, Within-subject Design Study.

Solmi M; Tiihonen J; Lähteenvuo M; Tanskanen A; Correll CU; Taipale H
Article: JOURNAL OF AFFECTIVE DISORDERS. 2021;295:1474-1481

Switches and early discontinuations of antidepressant medication in young adults with depression.

Lampela P; Tanskanen A; Lähteenvuo M; Tiihonen J; Taipale H
Article: JOURNAL OF AFFECTIVE DISORDERS. 2021;294:831-837

Persistence of antidepressant use among refugee youth with common mental disorder.

Taipale H; Niederkrotenthaler T; Tanskanen A; Cullen AE; Helgesson M; Berg L; Sijbrandij M; Klimek P; Mittendorfer-Rutz E
Article: EPIDEMIOLOGY AND PSYCHIATRIC SCIENCES. 2021;30:e67

Trajectories of labour market marginalisation among young adults with newly diagnosed attention-deficit/hyperactivity disorder (ADHD).

Helgesson M; Rahman S; Björkenstam E; Gustafsson K; Amin R; Taipale H; Tanskanen A; Ekselius L; Mittendorfer-Rutz E
Article: SCHIZOPHRENIA BULLETIN. 2021;47(6):1611-1620

Long-term Continuity of Antipsychotic Treatment for Schizophrenia: A Nationwide Study.

Rubio JM; Taipale H; Tanskanen A; Correll CU; Kane JM; Tiihonen J
Article: SCHIZOPHRENIA BULLETIN. 2021;47(6):1621-1630

Risk Factors, Incidence, and Outcomes of Neuroleptic Malignant Syndrome on Long-Acting Injectable vs Oral Antipsychotics in a Nationwide Schizophrenia Cohort.

Guinart D; Taipale H; Rubio JM; Tanskanen A; Correll CU; Tiihonen J; Kane JM
Article: LANCET PSYCHIATRY. 2021;8(10):883-891

Antipsychotic use and risk of breast cancer in women with schizophrenia: a nationwide nested case-control study in Finland.

Taipale H; Solmi M; Lähteenvuo M; Tanskanen A; Correll CU; Tiihonen J
Article: ADDICTION. 2021;116(8):1990-1998

Real-world effectiveness of pharmacological treatments of alcohol use disorders in a Swedish nation-wide cohort of 125 556 patients.

Heikkinen M; Taipale H; Tanskanen A; Mittendorfer-Rutz E; Lähteenvuo M; Tiihonen J
Article: SCHIZOPHRENIA BULLETIN. 2021;47(4):1099-1107

Long-Term Real-World Effectiveness of Pharmacotherapies for Schizoaffective Disorder.

Lintunen J; Taipale H; Tanskanen A; Mittendorfer-Rutz E; Tiihonen J; Lähteenvuo M
Article: ARCHIVES OF SUICIDE RESEARCH. 2021;25(3):424-438

Risk Factors for Suicide and Suicide Attempts Among Patients With Treatment-Resistant Depression: Nested Case-Control Study.

Reutfors J; Andersson TM-L; Tanskanen A; DiBernardo A; Li G; Brandt L; Brenner P
Article: ACTA PSYCHIATRICA SCANDINAVICA. 2021;144(1):42-49

Morbidity and mortality in schizophrenia with comorbid substance use disorders.

Lähteenvuo M; Batalla A; Luykx JJ; Mittendorfer-Rutz E; Tanskanen A; Tiihonen J; Taipale H
Article: INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 2021;36(7):1075-1084

Association of recent hospitalisation with antidepressant initiation among community dwellers with Alzheimer's disease.

Tarvainen A; Hartikainen S; Taipale H; Tanskanen A; Koponen M; Tolppanen A-M
Article: JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION. 2021;22(7):1543-1547.e3

Does Recent Hospitalization Increase Antipsychotic Initiation Among Community Dwellers With Alzheimer's Disease?

Hakala A; Tolppanen A-M; Koponen M; Taipale H; Tanskanen A; Hartikainen S; Tiihonen M
Article: NORDIC JOURNAL OF PSYCHIATRY. 2021;75(5):315-322

Antipsychotic use among persons with schizophrenia in Sweden and Finland, trends and differences.

Taipale H; Puranen A; Mittendorfer-Rutz E; Tiihonen J; Tanskanen A; Cervenka S; Lähteenvuo M
Article: SCHIZOPHRENIA RESEARCH. 2021;232:33-41

Molecular signaling pathways underlying schizophrenia.

Tiihonen J; Koskuvi M; Lähteenvuo M; Trontti K; Ojansuu I; Vaurio O; Cannon TD; Lönnqvist J; Therman S; Suvisaari J; Cheng L; Tanskanen A; Taipale H; Lehtonen Š; Koistinaho J
Article: ACTA PSYCHIATRICA SCANDINAVICA. 2021;143(6):487-494

Incidence of schizophrenia and influence of prenatal and infant exposure to viral infectious diseases.

Tanskanen A; Taipale H; Cannon M; Cotter D; Tiihonen J
Article: SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY. 2021;56(3):463-474

Initiation of antidepressant use among refugee and Swedish-born youth after diagnosis of a common mental disorder: findings from the REMAIN study.

Taipale H; Niederkrotenthaler T; Helgesson M; Sijbrandij M; Berg L; Tanskanen A; Mittendorfer-Rutz E
Article: SCHIZOPHRENIA RESEARCH. 2021;228:367-372

Effectiveness of pharmacotherapies for delusional disorder in a Swedish national cohort of 9076 patients.

Lähteenvuo M; Taipale H; Tanskanen A; Mittendorfer-Rutz E; Tiihonen J
Article: SCHIZOPHRENIA BULLETIN. 2021;47(1):23-30

Comparative Effectiveness of Antipsychotics for Risk of Attempted or Completed Suicide Among Persons With Schizophrenia.

Taipale H; Lähteenvuo M; Tanskanen A; Mittendorfer-Rutz E; Tiihonen J
Article: NPJ SCHIZOPHRENIA. 2021;7(1):1

Adenosine modulators and calcium channel blockers as add-on treatment for schizophrenia.

Lintunen J; Lähteenvuo M; Tiihonen J; Tanskanen A; Taipale H
Article: CLINICAL EPIDEMIOLOGY. 2021;13:295-307

Hip Fracture Risk in Antiepileptic Drug Initiators and Non-Initiators with Alzheimer's Disease.

Pisa F; Reinold J; Lavikainen P; Koponen M; Taipale H; Tanskanen A; Tiihonen J; Hartikainen S; Tolppanen A-M
Article: ACTA PSYCHIATRICA SCANDINAVICA. 2021;143(1):61-71

Employment among people with schizophrenia or bipolar disorder: A population-based study using nationwide registers.

Holm M; Taipale H; Tanskanen A; Tiihonen J; Mitterdorfer-Rutz E
Article: JOURNAL OF AFFECTIVE DISORDERS. 2020;277:885-892

Suicide mortality and use of psychotropic drugs in patients hospitalized due to bipolar disorder: A Finnish nationwide cohort study.

Antolín-Concha D; Lähteenvuo M; Vattulainen P; Tanskanen A; Taipale H; Vieta E; Tiihonen J
Article: CTS-CLINICAL AND TRANSLATIONAL SCIENCE. 2020;13(6):1170-1177

Persistence of Antipsychotic Use After Clozapine Discontinuation: A Real-World Study Across Antipsychotics.

Stam N; Taipale H; Tanskanen A; Isphording L; Okhuijsen-Pfeifer C; Schuiling-Veninga CCM; Bos JHJ; Bijker BJ; Tiihonen J; Luykx JJ
Article: JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES. 2020;75(11):2184-2192

Length of Hospital Stay for Hip Fracture and 30-Day Mortality in People With Alzheimer's Disease: A Cohort Study in Finland.

Lavikainen P; Koponen M; Taipale H; Tanskanen A; Tiihonen J; Hartikainen S; Tolppanen A-M
Article: JAMA NETWORK OPEN. 2020;3(10):e2019029

Incidence of and Characteristics Associated With Long-term Benzodiazepine Use in Finland.

Taipale H; Särkilä H; Tanskanen A; Kurko T; Taiminen T; Tiihonen J; Sund R; Tuulio-Henriksson A; Saastamoinen L; Hietala J
Article: BRITISH JOURNAL OF PSYCHIATRY. 2020;217(3):498-505

In the aftermath of clozapine discontinuation: comparative effectiveness and safety of antipsychotics in patients with schizophrenia who discontinue clozapine.

Luykx JJ; Stam N; Tanskanen A; Tiihonen J; Taipale H
Article: INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS. 2020;141:104142

Detection of medications associated with Alzheimer's disease using ensemble methods and cooperative game theory.

Braithwaite B; Paananen J; Taipale H; Tanskanen A; Tiihonen J; Hartikainen S; Tolppanen A-M
Article: MEDICAL CARE. 2020;58(9):763-769

Medication Use and Health Care Utilization After a Cost-sharing Increase in Schizophrenia: A Nationwide Analysis.

Hamina A; Tanskanen A; Tiihonen J; Taipale H
Article: PSYCHOLOGICAL MEDICINE. 2020;50(8):1356-1367

Psychosis breakthrough on antipsychotic maintenance: results from a nationwide study.

Rubio JM; Taipale H; Correll CU; Tanskanen A; Kane JM; Tiihonen J
Article: NEUROLOGY. 2020;94(20):e2099-e2108

Antiepileptic drug use and mortality among community-dwelling persons with Alzheimer disease.

Sarycheva T; Lavikainen P; Taipale H; Tiihonen J; Tanskanen A; Hartikainen S; Tolppanen A-M
Article: BMC PSYCHIATRY. 2020;20(1):232

Risk and risk factors for disability pension among patients with treatment resistant depression- a matched cohort study.

Taipale H; Reutfors J; Tanskanen A; Brandt L; Tiihonen J; DiBernardo A; Mittendorfer-Rutz E; Brenner P
Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2020;76(5):711-718

Use of antidepressants and mood stabilizers in persons with first-episode schizophrenia.

Puranen A; Koponen M; Tanskanen A; Tiihonen J; Taipale H
Article: NPJ SCHIZOPHRENIA. 2020;6(1):12

The clinical course of schizophrenia in women and men-a nation-wide cohort study.

Sommer IE; Tiihonen J; van Mourik A; Tanskanen A; Taipale H
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2020;105(4):dgz234-e972

Metformin and Risk of Alzheimer's Disease Among Community-Dwelling People With Diabetes: A National Case-Control Study.

Sluggett JK; Koponen M; Bell JS; Taipale H; Tanskanen A; Tiihonen J; Uusitupa M; Tolppanen A-M; Hartikainen S
Article: JOURNAL OF THE AMERICAN GERIATRICS SOCIETY. 2020;68(3):595-602

The Risk of Head Injuries Associated With Antipsychotic Use Among Persons With Alzheimer's disease.

Tapiainen V; Lavikainen P; Koponen M; Taipale H; Tanskanen A; Tiihonen J; Hartikainen S; Tolppanen A-M
Article: DRUGS & AGING. 2020;37(3):193-203

Opioid Use After Hospital Care due to Hip Fracture Among Community-Dwelling Persons With and Without Alzheimer's Disease.

Lintula E; Tiihonen M; Taipale H; Tolppanen A-M; Tanskanen A; Tiihonen J; Hartikainen S; Hamina A
Article: JOURNAL OF ALZHEIMERS DISEASE. 2020;73(3):1243-1251

Asthma and Chronic Obstructive Pulmonary Disease as a Comorbidity and Association with the Choice of Antidementia Medication Among Persons with Alzheimer's Disease.

Lampela P; Tolppanen A-M; Koponen M; Tanskanen A; Tiihonen J; Hartikainen S; Taipale H
Article: WORLD PSYCHIATRY. 2020;19(1):61-68

20-year follow-up study of physical morbidity and mortality in relationship to antipsychotic treatment in a nationwide cohort of 62,250 patients with schizophrenia (FIN20).

Taipale H; Tanskanen A; Mehtälä J; Vattulainen P; Correll CU; Tiihonen J
Article: SCHIZOPHRENIA RESEARCH. 2020;216:229-234

Childhood temperament and its association with adult psychiatric disorders in a prospective cohort study.

Brannigan R; Cannon M; Tanskanen A; Huttunen MO; Leacy FP; Clarke MC
Article: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2020;300:221-225

Prevalence of cardiovascular drug use before and after diagnosis of Alzheimer's disease.

Vu M; Koponen M; Taipale H; Tanskanen A; Tiihonen J; Kettunen R; Hartikainen S; Tolppanen A-M
Article: BRITISH JOURNAL OF PSYCHIATRY. 2020;216(2):85-89

The role of prenatal stress as a pathway to personality disorder: longitudinal birth cohort study.

Brannigan R; Tanskanen A; Huttunen MO; Cannon M; Leacy FP; Clarke MC
Article: SCIENTIFIC REPORTS. 2020;10(1):1219

Health and work disability outcomes in parents of patients with schizophrenia associated with antipsychotic exposure by the offspring.

Taipale H; Rahman S; Tanskanen A; Mehtälä J; Hoti F; Jedenius E; Enkusson D; Leval A; Sermon J; Tiihonen J; Mittendorfer-Rutz E
Article: JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION. 2019;20(12):1488-1494.e3

Accumulation of Hospital Days Among Antipsychotic Initiators With Alzheimer's Disease.

Koponen M; Lavikainen P; Taipale H; Tanskanen A; Tiihonen J; Hartikainen S; Tolppanen A-M
Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2019;75(10):1421-1430

Adherence to psychotropic medication in completed suicide in Sweden 2006-2013: a forensic-toxicological matched case-control study.

Forsman J; Taipale H; Masterman T; Tiihonen J; Tanskanen A
Article: ANNALS OF MEDICINE. 2019;51(5-6):294-305

Predictors of high hospital care and medication costs and cost trajectories in community-dwellers with Alzheimer's disease.

Kalamägi J; Lavikainen P; Taipale H; Tanskanen A; Tiihonen J; Hartikainen S; Tolppanen A-M
Article: OSTEOPOROSIS INTERNATIONAL. 2019;30(7):1481-1489

Long-term thiazide use and risk of low-energy fractures among persons with Alzheimer's disease-nested case-control study.

Taipale H; Rysä J; Hukkanen J; Koponen M; Tanskanen A; Tiihonen J; Kröger H; Hartikainen S; Tolppanen A-M
Article: SCHIZOPHRENIA BULLETIN. 2019;45(4):794-803

Burden for Parents of Patients With Schizophrenia-A Nationwide Comparative Study of Parents of Offspring With Rheumatoid Arthritis, Multiple Sclerosis, Epilepsy, and Healthy Controls.

Mittendorfer-Rutz E; Rahman S; Tanskanen A; Majak M; Mehtälä J; Hoti F; Jedenius E; Enkusson D; Leval A; Sermon J; Taipale H; Tiihonen J
Article: JOURNAL OF ALZHEIMERS DISEASE. 2019;69(3):807-816

Hospital-Treated Pneumonia Associated with Opioid Use Among Community Dwellers with Alzheimer's Disease.

Hamina A; Taipale H; Karttunen N; Tanskanen A; Tiihonen J; Tolppanen A-M; Hartikainen S
Article: JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION. 2019;20(6):751-758

Antiepileptic Drugs and Accumulation of Hospital Days Among Persons With Alzheimer's Disease.

Lavikainen P; Taipale H; Tanskanen A; Koponen M; Tiihonen J; Hartikainen S; Tolppanen A-M
Article: JAMA PSYCHIATRY. 2019;76(5):499-507

Association of Antipsychotic Polypharmacy vs Monotherapy With Psychiatric Rehospitalization Among Adults With Schizophrenia.

Tiihonen J; Taipale H; Mehtälä J; Vattulainen P; Correll CU; Tanskanen A
Article: JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH. 2019;73(5):451-454

Incidence of head injury and traumatic brain injury among people with Alzheimer's disease.

Ilmaniemi S; Taipale H; Tanskanen A; Tiihonen J; Hartikainen S; Tolppanen A-M
Article: ACTA PSYCHIATRICA SCANDINAVICA. 2019;139(4):304-310

The association between subjective maternal stress during pregnancy and offspring clinically diagnosed psychiatric disorders.

Brannigan R; Cannon M; Tanskanen A; Huttunen MO; Leacy FP; Clarke MC
Article: JOURNAL OF ALZHEIMERS DISEASE. 2019;68(1):127-136

Antiepileptic Drug Use Is Associated with an Increased Risk of Pneumonia Among Community-Dwelling Persons with Alzheimer's Disease-Matched Cohort Study.

Taipale H; Lampela P; Koponen M; Tanskanen A; Tiihonen J; Hartikainen S; Tolppanen A-M
Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2019;75(3):417-425

Duration of new antidepressant use and factors associated with discontinuation among community-dwelling persons with Alzheimer's disease.

Kettunen R; Taipale H; Tolppanen A-M; Tanskanen A; Tiihonen J; Hartikainen S; Koponen M
Article: INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 2019;34(2):280-288

Concomitant use of benzodiazepines and opioids in community-dwelling older people with or without Alzheimer's disease-A nationwide register-based study in Finland.

Karttunen N; Taipale H; Hamina A; Tanskanen A; Tiihonen J; Tolppanen A-M; Hartikainen S
Article: PAIN. 2019;160(2):417-423

Incident opioid use and risk of hip fracture among persons with Alzheimer disease: a nationwide matched cohort study.

Taipale H; Hamina A; Karttunen N; Koponen M; Tanskanen A; Tiihonen J; Hartikainen S; Tolppanen A-M
Article: ACTA PSYCHIATRICA SCANDINAVICA. 2018;138(6):492-499

Mortality in schizophrenia: 30-year nationwide follow-up study.

Tanskanen A; Tiihonen J; Taipale H
Article: PAIN MEDICINE. 2018;19(11):2115-2121

Is Alzheimer's Disease Associated with Previous Opioid Use?

Taipale H; Hamina A; Lampela P; Tanskanen A; Tiihonen J; Karttunen N; Tolppanen A-M; Hartikainen S
Article: BIPOLAR DISORDERS. 2018;20(7):634-646

Initiation and long-term use of benzodiazepines and Z-drugs in bipolar disorder.

Wingård L; Taipale H; Reutfors J; Westerlund A; Bodén R; Tiihonen J; Tanskanen A; Andersen M
Article: DRUGS & AGING. 2018;35(11):985-992

Systemic Estrogen Use and Discontinuation After Alzheimer's Disease Diagnosis in Finland 2005-2012: A Nationwide Exposure-Matched Cohort Study.

Tolppanen A-M; Tiihonen M; Taipale H; Koponen M; Tanskanen A; Lavikainen P; Tiihonen J; Hartikainen S
Article: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2018;28(11):1260-1269

Psychotropic drugs use and psychotropic polypharmacy among persons with Alzheimer's disease.

Orsel K; Taipale H; Tolppanen A-M; Koponen M; Tanskanen A; Tiihonen J; Gardarsdottir H; Hartikainen S
Article: SCHIZOPHRENIA BULLETIN. 2018;44(6):1381-1387

Comparative Effectiveness of Antipsychotic Drugs for Rehospitalization in Schizophrenia-A Nationwide Study With 20-Year Follow-up.

Taipale H; Mehtälä J; Tanskanen A; Tiihonen J
Article: JOURNAL OF ALZHEIMERS DISEASE. 2018;66(1):387-395

Incidence and Prevalence of Antiepileptic Medication Use in Community-Dwelling Persons with and without Alzheimer's Disease.

Sarycheva T; Taipale H; Lavikainen P; Tiihonen J; Tanskanen A; Hartikainen S; Tolppanen A-M
Article: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2018;27(10):1112-1122

Comparison of dispensed medications and forensic-toxicological findings to assess pharmacotherapy in the Swedish population 2006 to 2013.

Forsman J; Taipale H; Masterman T; Tiihonen J; Tanskanen A
Article: JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY. 2018;38(5):494-497

Antipsychotic Use and the Risk of Initiating Medication for Benign Prostate Hyperplasia in Persons With Alzheimer Disease: A Matched Cohort Study.

Orsel K; Taipale H; Raatikainen S; Lampela P; Tolppanen A-M; Koponen M; Tanskanen A; Tiihonen J; Gardarsdottir H; Hartikainen S
Article: JOURNAL OF THE AMERICAN HEART ASSOCIATION. 2018;7(18):e009742

Antiepileptic Drug Use and the Risk of Stroke Among Community-Dwelling People With Alzheimer Disease: A Matched Cohort Study.

Sarycheva T; Lavikainen P; Taipale H; Tiihonen J; Tanskanen A; Hartikainen S; Tolppanen A-M
Article: AMERICAN JOURNAL OF PSYCHIATRY. 2018;175(8):765-773

20-Year Nationwide Follow-Up Study on Discontinuation of Antipsychotic Treatment in First-Episode Schizophrenia.

Tiihonen J; Tanskanen A; Taipale H
Article: ACTA PSYCHIATRICA SCANDINAVICA. 2018;138(2):91-100

The risk of Alzheimer's disease associated with benzodiazepines and related drugs: a nested case-control study.

Tapiainen V; Taipale H; Tanskanen A; Tiihonen J; Hartikainen S; Tolppanen A-M
Article: SCHIZOPHRENIA RESEARCH. 2018;197:274-280

Antipsychotics and mortality in a nationwide cohort of 29,823 patients with schizophrenia.

Taipale H; Mittendorfer-Rutz E; Alexanderson K; Majak M; Mehtälä J; Hoti F; Jedenius E; Enkusson D; Leval A; Sermon J; Tanskanen A; Tiihonen J
Article: JOURNAL OF THE AMERICAN GERIATRICS SOCIETY. 2018;66(6):1123-1129

Use of Antiepileptic Drugs and Dementia Risk-an Analysis of Finnish Health Register and German Health Insurance Data.

Taipale H; Gomm W; Broich K; Maier W; Tolppanen A-M; Tanskanen A; Tiihonen J; Hartikainen S; Haenisch B
Article: INTERNATIONAL PSYCHOGERIATRICS. 2018;30(7):947-956

Impact of opioid initiation on antipsychotic and benzodiazepine and related drug use among persons with Alzheimer's disease.

Hamina A; Lavikainen P; Tanskanen A; Tolppanen A-M; Tiihonen J; Hartikainen S; Taipale H
Article: JOURNAL OF ALZHEIMERS DISEASE. 2018;64(2):437-445

Hospitalization after Oral Antibiotic Initiation in Finnish Community Dwellers with and without Alzheimer's Disease: Retrospective Register-Based Cohort Study.

Järvinen H; Taipale H; Koponen M; Tanskanen A; Tiihonen J; Tolppanen A-M; Hartikainen S
Article: INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 2018;33(4):583-590

Risk of death associated with new benzodiazepine use among persons with Alzheimer disease: A matched cohort study.

Saarelainen L; Tolppanen A-M; Koponen M; Tanskanen A; Tiihonen J; Hartikainen S; Taipale H
Article: ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2018;47(8):1135-1142

Proton pump inhibitor use and risk of hip fractures among community-dwelling persons with Alzheimer's disease-a nested case-control study.

Torvinen-Kiiskinen S; Tolppanen A-M; Koponen M; Tanskanen A; Tiihonen J; Hartikainen S; Taipale H
Article: JAMA PSYCHIATRY. 2018;75(4):347-355

Real-world Effectiveness of Pharmacologic Treatments for the Prevention of Rehospitalization in a Finnish Nationwide Cohort of Patients With Bipolar Disorder.

Lähteenvuo M; Tanskanen A; Taipale H; Hoti F; Vattulainen P; Vieta E; Tiihonen J
Article: JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION. 2018;19(3):193-199

Research Priorities for Optimizing Geriatric Pharmacotherapy: An International Consensus.

Tan ECK; Sluggett JK; Johnell K; Onder G; Elseviers M; Morin L; Vetrano DL; Wastesson JW; Fastbom J; Taipale H; Tanskanen A; Bell JS; Optimizing Geriatric Pharmacotherapy through Pharm
Article: BMC PSYCHIATRY. 2018;18(1):47

Trajectories of antidepressant medication use in individuals before and after being granted disability pension due to common mental disorders- a nationwide register-based study.

Rahman S; Wiberg M; Alexanderson K; Jokinen J; Tanskanen A; Mittendorfer-Rutz E
Article: ORNIS FENNICA. 2018;95(2):49-60

Can common forest bird species tolerate disturbances in neighbouring areas? A case study of the Vuosaari Harbour construction in southern Finland

Yrjola RA; Tanskanen A; Sarvanne H; Vickholm J; Lehikoinen A
Article: AMERICAN JOURNAL OF GASTROENTEROLOGY. 2017;112(12):1802-1808

No Association Between Proton Pump Inhibitor Use and Risk of Alzheimer's Disease.

Taipale H; Tolppanen A-M; Tiihonen M; Tanskanen A; Tiihonen J; Hartikainen S
Article: INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 2017;32(12):e107-e115

Antidepressant use and risk of hip fractures among community-dwelling persons with and without Alzheimer's disease.

Torvinen-Kiiskinen S; Tolppanen A-M; Koponen M; Tanskanen A; Tiihonen J; Hartikainen S; Taipale H
Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2017;73(9):1149-1158

Long-term use of proton pump inhibitors among community-dwelling persons with and without Alzheimer's disease.

Juntunen H; Taipale H; Tanskanen A; Tolppanen A-M; Tiihonen J; Hartikainen S; Tiihonen M
Article: ANNALS OF PHARMACOTHERAPY. 2017;51(9):725-734

Incident Use of a Potentially Inappropriate Medication and Hip Fracture in Community-Dwelling Older Persons With Alzheimer's Disease.

Hyttinen V; Taipale H; Tolppanen A-M; Tanskanen A; Tiihonen J; Hartikainen S; Valtonen H
Article: JOURNAL OF AFFECTIVE DISORDERS. 2017;217:16-23

Reducing the rehospitalization risk after a manic episode: A population based cohort study of lithium, valproate, olanzapine, quetiapine and aripiprazole in monotherapy and combinations.

Wingård L; Bodén R; Brandt L; Tiihonen J; Tanskanen A; Kieler H; Andersen M; Reutfors J
Article: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2017;26(8):875-889

Screening approach for identifying candidate drugs and drug-drug interactions related to hip fracture risk in persons with Alzheimer disease.

Tolppanen A-M; Taipale H; Koponen M; Tanskanen A; Lavikainen P; Paananen J; Tiihonen J; Hartikainen S
Article: ALZHEIMERS RESEARCH & THERAPY. 2017;9(1):59

Risk of head and traumatic brain injuries associated with antidepressant use among community-dwelling persons with Alzheimer's disease: a nationwide matched cohort study.

Taipale H; Koponen M; Tanskanen A; Lavikainen P; Sund R; Tiihonen J; Hartikainen S; Tolppanen A-M
Article: LANCET PSYCHIATRY. 2017;4(7):547-553

Pharmacological treatments and risk of readmission to hospital for unipolar depression in Finland: a nationwide cohort study.

Tiihonen J; Tanskanen A; Hoti F; Vattulainen P; Taipale H; Mehtälä J; Lähteenvuo M
Article: JAMA PSYCHIATRY. 2017;74(7):686-693

Real-World Effectiveness of Antipsychotic Treatments in a Nationwide Cohort of 29 823 Patients With Schizophrenia.

Tiihonen J; Mittendorfer-Rutz E; Majak M; Mehtälä J; Hoti F; Jedenius E; Enkusson D; Leval A; Sermon J; Tanskanen A; Taipale H
Article: INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY. 2017;32(3):135-141

Use of benzodiazepines and related drugs is associated with a risk of stroke among persons with Alzheimer's disease.

Taipale H; Koponen M; Tanskanen A; Lavikainen P; Tolppanen A-M; Sund R; Tiihonen J; Hartikainen S
Article: CANADIAN MEDICAL ASSOCIATION JOURNAL. 2017;189(14):E519-E529

Risk of pneumonia associated with incident benzodiazepine use among community-dwelling adults with Alzheimer disease.

Taipale H; Tolppanen A-M; Koponen M; Tanskanen A; Lavikainen P; Sund R; Tiihonen J; Hartikainen S
Article: ANNALS OF MEDICINE. 2017;49(3):230-239

Use of antidementia drugs and risk of pneumonia in older persons with Alzheimer's disease.

Lampela P; Tolppanen A-M; Tanskanen A; Tiihonen J; Lavikainen P; Hartikainen S; Taipale H
Article: MATURITAS. 2017;98:7-13

Risk of Alzheimer's disease among users of postmenopausal hormone therapy: A nationwide case-control study.

Imtiaz B; Taipale H; Tanskanen A; Tiihonen M; Kivipelto M; Heikkinen A-M; Tiihonen J; Soininen H; Hartikainen S; Tolppanen A-M
Article: EUROPEAN JOURNAL OF PAIN. 2017;21(4):658-667

Differences in analgesic use in community-dwelling persons with and without Alzheimer's disease.

Hamina A; Taipale H; Tanskanen A; Tolppanen A-M; Tiihonen J; Hartikainen S
Article: JOURNAL OF CLINICAL PSYCHIATRY. 2017;78(3):e257-e263

Antipsychotic Use and the Risk of Hip Fracture Among Community-Dwelling Persons With Alzheimer's Disease.

Koponen M; Taipale H; Lavikainen P; Tanskanen A; Tiihonen J; Tolppanen A-M; Ahonen R; Hartikainen S
Article: PAIN. 2017;158(2):252-260

Long-term use of opioids for nonmalignant pain among community-dwelling persons with and without Alzheimer disease in Finland: a nationwide register-based study.

Hamina A; Taipale H; Tanskanen A; Tolppanen A-M; Karttunen N; Pylkkänen L; Tiihonen J; Hartikainen S
Article: JOURNAL OF ALZHEIMERS DISEASE. 2017;56(1):107-118

Risk of Mortality Associated with Antipsychotic Monotherapy and Polypharmacy Among Community-Dwelling Persons with Alzheimer's Disease.

Koponen M; Taipale H; Lavikainen P; Tanskanen A; Tiihonen J; Tolppanen A-M; Ahonen R; Hartikainen S
Article: JOURNAL OF ALZHEIMERS DISEASE. 2017;56(1):119-128

Anticholinergic Exposure and Risk of Pneumonia in Persons with Alzheimer's Disease: A Nested Case-Control Study.

Lampela P; Tolppanen A-M; Tanskanen A; Tiihonen J; Hartikainen S; Taipale H
Article: PLOS ONE. 2017;12(3):e0173450

Regional changes in psychotropic use among Finnish persons with newly diagnosed Alzheimer's disease in 2005-2011.

Tolppanen A-M; Voutilainen A; Taipale H; Tanskanen A; Lavikainen P; Koponen M; Tiihonen J; Hartikainen S
Article: INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 2017;32(1):94-101

Incidence of antidepressant use in community-dwelling persons with and without Alzheimer's disease: 13-year follow-up.

Puranen A; Taipale H; Koponen M; Tanskanen A; Tolppanen A-M; Tiihonen J; Hartikainen S
Article: PLOS ONE. 2017;12(9):e0184070

Drug exposure in register-based research-An expert-opinion based evaluation of methods.

Tanskanen A; Taipale H; Koponen M; Tolppanen A-M; Hartikainen S; Ahonen R; Tiihonen J
Article: DRUGS & AGING. 2017;34(1):55-65

A Comparison of Sex Differences in Psychotropic Medication Use in Older People with Alzheimer's Disease in the US and Finland.

Moga DC; Taipale H; Tolppanen A-M; Tanskanen A; Tiihonen J; Hartikainen S; Wu Q; Jicha GA; Gnjidic D
Article: JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION. 2017;18(1):87.e15-87.e21

Risk of Hip Fracture in Benzodiazepine Users With and Without Alzheimer Disease.

Saarelainen L; Tolppanen A-M; Koponen M; Tanskanen A; Sund R; Tiihonen J; Hartikainen S; Taipale H
Article: DRUGS & AGING. 2017;34(1):67-77

Risk Factors for Initiation of Potentially Inappropriate Medications in Community-Dwelling Older Adults with and without Alzheimer's Disease.

Hyttinen V; Taipale H; Tanskanen A; Tiihonen J; Tolppanen A-M; Hartikainen S; Valtonen H
Article: CHEST. 2016;150(6):1233-1241

Antipsychotic Use and Risk of Hospitalization or Death Due to Pneumonia in Persons With and Those Without Alzheimer Disease.

Tolppanen A-M; Koponen M; Tanskanen A; Lavikainen P; Sund R; Tiihonen J; Hartikainen S; Taipale H
Article: BMC GERIATRICS. 2016;16(1):204

Comparison of predictors of hip fracture and mortality after hip fracture in community-dwellers with and without Alzheimer's disease - exposure-matched cohort study.

Tolppanen A-M; Taipale H; Tanskanen A; Tiihonen J; Hartikainen S
Article: ANNALES ZOOLOGICI FENNICI. 2016;53(5-6):241-254

Effects of human activities on populations of wetland birds: a case study from Vuosaari Harbour, southern Finland

Yrjola RA; Tanskanen A; Sarvanne H; Vickholm J; Santaharju JLM
Article: AGE AND AGEING. 2016;45(6):900-904

Drug use in persons with and without Alzheimer's disease aged 90 years or more.

Taipale H; Koponen M; Tanskanen A; Tolppanen A-M; Tiihonen J; Hartikainen S
Article: BMJ OPEN. 2016;6(7):e012100

Cohort profile: the Finnish Medication and Alzheimer's disease (MEDALZ) study.

Tolppanen A-M; Taipale H; Koponen M; Lavikainen P; Tanskanen A; Tiihonen J; Hartikainen S
Article: AMERICAN JOURNAL OF PSYCHIATRY. 2016;173(6):600-606

Mortality and Cumulative Exposure to Antipsychotics, Antidepressants, and Benzodiazepines in Patients With Schizophrenia: An Observational Follow-Up Study.

Tiihonen J; Mittendorfer-Rutz E; Torniainen M; Alexanderson K; Tanskanen A
Article: JOURNAL OF ALZHEIMERS DISEASE. 2016;52(1):127-132

Incidence and Duration of Cumulative Bisphosphonate Use among Community-Dwelling Persons with or without Alzheimer's Disease.

Tiihonen M; Taipale H; Tanskanen A; Tiihonen J; Hartikainen S
Article: SCANDINAVIAN JOURNAL OF PUBLIC HEALTH. 2016;44(2):150-158

Hospital care and drug costs from five years before until two years after the diagnosis of Alzheimer's disease in a Finnish nationwide cohort.

Taipale H; Purhonen M; Tolppanen A-M; Tanskanen A; Tiihonen J; Hartikainen S
Article: JOURNAL OF PREVENTIVE MEDICINE AND PUBLIC HEALTH. 2016;49(2):134-138

Month and Season of Birth as a Risk Factor for Alzheimer's Disease: A Nationwide Nested Case-control Study.

Tolppanen A-M; Ahonen R; Koponen M; Lavikainen P; Purhonen M; Taipale H; Tanskanen A; Tiihonen J; Tiihonen M; Hartikainen S
Article: DUODECIM; LAAKETIETEELLINEN AIKAKAUSKIRJA. 2016;132(2):181

[Mortality and cumulative exposure to antipsychotics, antidepressants and benzodiazepines in patients with schizophrenia: an observational follow-up study].

Tiihonenl J; Mittendorfer-Rutz E; Torniainen M; Alexanderson K; Tanskanen A
Article: CLINICAL EPIDEMIOLOGY. 2016;8:363-371

Agreement between PRE2DUP register data modeling method and comprehensive drug use interview among older persons.

Taipale H; Tanskanen A; Koponen M; Tolppanen A-M; Tiihonen J; Hartikainen S
Article: JOURNAL OF ALZHEIMERS DISEASE. 2015;49(3):809-818

The Incidence of Benzodiazepine and Related Drug Use in Persons with and without Alzheimer's Disease.

Saarelainen L; Taipale H; Koponen M; Tanskanen A; Tolppanen A-M; Tiihonen J; Hartikainen S
Article: DRUGS & AGING. 2015;32(11):937-945

Prevalence of Drug Combinations Increasing Bleeding Risk Among Warfarin Users With and Without Alzheimer's Disease.

Taipale H; Vuorikari H; Tanskanen A; Koponen M; Tiihonen J; Kettunen R; Hartikainen S
Article: BRITISH JOURNAL OF PSYCHIATRY. 2015;207(5):444-449

Incidence of antipsychotic use in relation to diagnosis of Alzheimer's disease among community-dwelling persons.

Koponen M; Tolppanen A-M; Taipale H; Tanskanen A; Tiihonen J; Johnell K; Fastbom J; Ahonen R; Hartikainen S
Article: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2015;25(10):1706-1713

Long-term use of antipsychotics among community-dwelling persons with Alzheimer׳s disease: A nationwide register-based study.

Koponen M; Taipale H; Tanskanen A; Tolppanen A-M; Tiihonen J; Ahonen R; Hartikainen S
Article: JOURNAL OF AFFECTIVE DISORDERS. 2015;183:159-165

Lithium is associated with decrease in all-cause and suicide mortality in high-risk bipolar patients: A nationwide registry-based prospective cohort study.

Toffol E; Hätönen T; Tanskanen A; Lönnqvist J; Wahlbeck K; Joffe G; Tiihonen J; Haukka J; Partonen T
Article: INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY. 2015;30(4):202-208

Long-term use of benzodiazepines and related drugs among community-dwelling individuals with and without Alzheimer's disease.

Taipale H; Koponen M; Tanskanen A; Tolppanen A-M; Tiihonen J; Hartikainen S
Article: URBAN ECOSYSTEMS. 2015;18(2):341-354

Roadside and riverside green - urban corridors in the city of Vantaa, Finland

Ranta P; Kesulahti J; Tanskanen A; Viljanen V; Virtanen T
Article: SCHIZOPHRENIA BULLETIN. 2015;41(3):656-663

Antipsychotic treatment and mortality in schizophrenia.

Torniainen M; Mittendorfer-Rutz E; Tanskanen A; Björkenstam C; Suvisaari J; Alexanderson K; Tiihonen J
Article: BMC MEDICAL INFORMATICS AND DECISION MAKING. 2015;15:21

From prescription drug purchases to drug use periods – a second generation method (PRE2DUP).

Tanskanen A; Taipale H; Koponen M; Tolppanen A-M; Hartikainen S; Ahonen R; Tiihonen J
Article: JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY. 2014;34(6):722-727

Concomitant use of acetylcholine esterase inhibitors and urinary antispasmodics among Finnish community-dwelling persons with Alzheimer disease.

Torvinen-Kiiskinen S; Taipale H; Tanskanen A; Tiihonen J; Hartikainen S
Article: BMC RESEARCH NOTES. 2014;7:796

From prescriptions to drug use periods - things to notice.

Tanskanen A; Taipale H; Koponen M; Tolppanen A-M; Hartikainen S; Ahonen R; Tiihonen J
Article: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2014;24(11):1729-1737

High prevalence of psychotropic drug use among persons with and without Alzheimer's disease in Finnish nationwide cohort.

Taipale H; Koponen M; Tanskanen A; Tolppanen A-M; Tiihonen J; Hartikainen S
Article: JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY. 2014;34(4):435-440

Antipsychotic doses among community-dwelling persons with Alzheimer disease in Finland.

Taipale H; Koponen M; Tanskanen A; Tolppanen A-M; Tiihonen J; Hartikainen S
Article: JOURNAL OF ALZHEIMERS DISEASE. 2014;41(4):1223-1228

Antipsychotic polypharmacy among a nationwide sample of community-dwelling persons with Alzheimer's disease.

Taipale H; Koponen M; Tanskanen A; Tolppanen A-M; Tiihonen J; Hartikainen S
Article: INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY. 2014;29(4):216-223

Antidementia drug use among community-dwelling individuals with Alzheimer's disease in Finland: a nationwide register-based study.

Taipale H; Tanskanen A; Koponen M; Tolppanen A-M; Tiihonen J; Hartikainen S
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2014;111(9):3520-3525

Distance to health services affects local-level vaccine efficacy for pneumococcal conjugate vaccine (PCV) among rural Filipino children.

Root ED; Lucero M; Nohynek H; Anthamatten P; Thomas DSK; Tallo V; Tanskanen A; Quiambao BP; Puumalainen T; Lupisan SP; Ruutu P; Ladesma E; Williams GM; Riley I; Simões EAF
Article: VACCINE. 2013;32(1):159-164

Design questions for Streptococcus pneumoniae vaccine trials with a colonisation endpoint.

Auranen K; Rinta-Kokko H; Goldblatt D; Nohynek H; O'Brien KL; Satzke C; Simell B; Tanskanen A; Käyhty H
Article: SCHIZOPHRENIA BULLETIN. 2013;39(5):1067-1076

Genetic risk for schizophrenia, obstetric complications, and adolescent school outcome: evidence for gene-environment interaction.

Forsyth JK; Ellman LM; Tanskanen A; Mustonen U; Huttunen MO; Suvisaari J; Cannon TD
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2013;48(1):42-50

Medication use among inflammatory bowel disease patients: excessive consumption of antidepressants and analgesics.

Haapamäki J; Tanskanen A; Roine RP; Blom M; Turunen U; Mäntylä J; Färkkilä MA; Arkkila PET
Article: CLINICAL EPIDEMIOLOGY. 2013;5:277-285

Use of existing data sources in clinical epidemiology: Finnish health care registers in Alzheimer's disease research - the Medication use among persons with Alzheimer's disease (MEDALZ-2005) study.

Tolppanen A-M; Taipale H; Koponen M; Lavikainen P; Tanskanen A; Tiihonen J; Hartikainen S
Article: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2012;21(11):1227-1231

Outcome of patients after market withdrawal of thioridazine: a retrospective analysis in a nationwide cohort.

Purhonen M; Koponen H; Tiihonen J; Tanskanen A
Article: BIOLOGICAL PSYCHIATRY. 2012;71(9):836-839

Evidence for shared susceptibility to epilepsy and psychosis: a population-based family study.

Clarke MC; Tanskanen A; Huttunen MO; Clancy M; Cotter DR; Cannon M
Article: BMC RESEARCH NOTES. 2012;5:51

Geographic Information System and tools of spatial analysis in a pneumococcal vaccine trial.

Tanskanen A; Nillos LT; Lehtinen A; Nohynek H; Sanvictores DHM; Simões EA; Tallo VL; Lucero MG; ARIVAC Consortium
Article: SCHIZOPHRENIA RESEARCH. 2011;133(1-3):125-132

Advanced paternal age and parental history of schizophrenia.

Miller B; Suvisaari J; Miettunen J; Järvelin M-R; Haukka J; Tanskanen A; Lönnqvist J; Isohanni M; Kirkpatrick B
Article: AMERICAN JOURNAL OF PSYCHIATRY. 2011;168(12):1295-1302

Increased risk of schizophrenia from additive interaction between infant motor developmental delay and obstetric complications: evidence from a population-based longitudinal study.

Clarke MC; Tanskanen A; Huttunen M; Leon DA; Murray RM; Jones PB; Cannon M
Article: SCHIZOPHRENIA RESEARCH. 2010;121(1-3):218-226

Paternal age and mortality in nonaffective psychosis.

Miller B; Pihlajamaa J; Haukka J; Cannon M; Henriksson M; Heilä H; Huttunen M; Tanskanen A; Lönnqvist J; Suvisaari J; Kirkpatrick B
Article: AMERICAN JOURNAL OF EPIDEMIOLOGY. 2010;171(2):169-176

Between-strain competition in acquisition and clearance of pneumococcal carriage--epidemiologic evidence from a longitudinal study of day-care children.

Auranen K; Mehtälä J; Tanskanen A; S Kaltoft M
Article: INTERNATIONAL JOURNAL OF CANCER. 2010;126(1):279-284

Incidence of cancer and statin usage--record linkage study.

Haukka J; Sankila R; Klaukka T; Lonnqvist J; Niskanen L; Tanskanen A; Wahlbeck K; Tiihonen J
Article: INTERNATIONAL JOURNAL OF CANCER. 2010;126(1):285-296

Incidence of cancer and antidepressant medication: record linkage study.

Haukka J; Sankila R; Klaukka T; Lonnqvist J; Niskanen L; Tanskanen A; Wahlbeck K; Tiihonen J
Article: LANCET. 2009;374(9690):620-627

11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study).

Tiihonen J; Lönnqvist J; Wahlbeck K; Klaukka T; Niskanen L; Tanskanen A; Haukka J
Article: BMC INFECTIOUS DISEASES. 2008;8:173

Clustering of serotypes in a longitudinal study of Streptococcus pneumoniae carriage in three day care centres.

Leino T; Hoti F; Syrjänen R; Tanskanen A; Auranen K
Article: ARCHIVES OF GENERAL PSYCHIATRY. 2006;63(12):1358-1367

Antidepressants and the risk of suicide, attempted suicide, and overall mortality in a nationwide cohort.

Tiihonen J; Lönnqvist J; Wahlbeck K; Klaukka T; Tanskanen A; Haukka J
Article: CONSERVATION BIOLOGY. 2002;16(5):1398-1408

Method for selection of old-forest reserves

Siitonen P; Tanskanen A; Lehtinen A
Article: BRITISH JOURNAL OF PSYCHIATRY. 2002;180:496-501

Perinatal and childhood risk factors for later criminality and violence in schizophrenia. Longitudinal, population-based study.

Cannon M; Huttunen MO; Tanskanen AJ; Arseneault L; Jones PB; Murray RM
Article: PSYCHOLOGICAL MEDICINE. 2000;30(2):315-324

Decreasing seasonal variation of births in schizophrenia.

Suvisaari JM; Haukka JK; Tanskanen AJ; Lönnqvist JK
Article: CONSERVATION BIOLOGY. 1999;13(6):1293-1300

Selection of islands for conservation in the urban archipelago of Helsinki, Finland

Ranta P; Tanskanen A; Niemelä J; Kurtto A
Article: HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL. 1999;14(7):491-497

Motor co-ordination deficits as predictors of schizophrenia among Finnish school children

Cannon M; Jones P; Huttunen MO; Tanskanen A; Murray RM
Article: AMERICAN JOURNAL OF PSYCHIATRY. 1999;156(7):1100-1102

Association between prenatal exposure to poliovirus infection and adult schizophrenia.

Suvisaari J; Haukka J; Tanskanen A; Hovi T; Lönnqvist J
Article: ARCHIVES OF GENERAL PSYCHIATRY. 1999;56(5):457-463

School performance in Finnish children and later development of schizophrenia: a population-based longitudinal study.

Cannon M; Jones P; Huttunen MO; Tanskanen A; Huttunen T; Rabe-Hesketh S; Murray RM
Article: BRITISH JOURNAL OF PSYCHIATRY. 1998;173:494-500

Age at onset and outcome in schizophrenia are related to the degree of familial loading.

Suvisaari JM; Haukka J; Tanskanen A; Lönnqvist JK
Show more

All other publications

Corrigendum: SCHIZOPHRENIA BULLETIN. 2023;49(1):228

Correction to: Optimal Doses of Specific Antipsychotics for Relapse Prevention in a Nationwide Cohort of Patients with Schizophrenia.
Letter: LANCET PSYCHIATRY. 2022;9(7):539-540

Clozapine and the risk of haematological malignancies - Authors' reply.

Tiihonen J; Tanskanen A; Bell JS; Dawson JL; Kataja V; Taipale H
Letter: LANCET PSYCHIATRY. 2022;9(7):536-537

Real-world effectiveness studies of low doses of antipsychotics - Authors' reply.

Taipale H; Tanskanen A; Correll CU; Tiihonen J
Review: NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS. 2022;136:104608

Half a century of research on antipsychotics and schizophrenia: A scientometric study of hotspots, nodes, bursts, and trends.

Sabe M; Pillinger T; Kaiser S; Chen C; Taipale H; Tanskanen A; Tiihonen J; Leucht S; Correll CU; Solmi M
Corrigendum: JAMA PSYCHIATRY. 2022;79(5):516

Errors in Figures 1 and 2.
Corrigendum: BRITISH JOURNAL OF PSYCHIATRY. 2020;216(5):285

The role of prenatal stress as a pathway to personality disorder: longitudinal birth cohort study - CORRIGENDUM.

Brannigan R; Tanskanen A; Huttunen MO; Cannon M; Leacy FP; Clarke MC
Letter: AMERICAN JOURNAL OF PSYCHIATRY. 2018;175(12):1267

Risk of Treatment Failure: Response to Ghosh and Noble.

Tiihonen J; Tanskanen A; Taipale H
Letter: AMERICAN JOURNAL OF PSYCHIATRY. 2018;175(9):909

Risk of Treatment Failure: Response to Czobor and Volavka.

Tiihonen J; Tanskanen A; Taipale H
Editorial comment: ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2018;47(11):1544-1545

Editorial: let's take a break from studying the PPI-fracture association-Authors' reply.

Torvinen-Kiiskinen S; Tolppanen A-M; Koponen M; Tanskanen A; Tiihonen J; Hartikainen S; Taipale H
Corrigendum: SCHIZOPHRENIA BULLETIN. 2016;42(2):528

Erratum. Antipsychotic treatment and mortality in schizophrenia.

Torniainen M; Mittendorfer-Rutz E; Tanskanen A; Björkenstam C; Suvisaari J; Alexanderson K; Tiihonen J
Letter: WORLD PSYCHIATRY. 2015;14(2):245-247

Psychotropic drugs and homicide: A prospective cohort study from Finland.

Tiihonen J; Lehti M; Aaltonen M; Kivivuori J; Kautiainen H; Virta LJ; Hoti F; Tanskanen A; Korhonen P
Review: VACCINE. 2013;32(1):153-158

Colonisation endpoints in Streptococcus pneumoniae vaccine trials.

Auranen K; Rinta-Kokko H; Goldblatt D; Nohynek H; O'Brien KL; Satzke C; Simell B; Tanskanen A; Käyhty H; Pneumococcal Carriage Group (PneumoCarr)
Published paper: SCHIZOPHRENIA RESEARCH. 2013;143(2-3):363-366

Sudden death of father or sibling in early childhood increases risk for psychotic disorder.

Clarke MC; Tanskanen A; Huttunen MO; Cannon M
Letter: BMC RESEARCH NOTES. 2012;5:274

The data management of a phase III efficacy trial of an 11-valent pneumococcal conjugate vaccine and related satellite studies conducted in the Philippines.

Sanvictores DHM; Lucero MG; Nohynek H; Tallo VL; Tanskanen A; Nillos LT; Williams G; ARIVAC Consortium
Published paper: AMERICAN JOURNAL OF PSYCHIATRY. 2009;166(9):1025-1030

Evidence for an interaction between familial liability and prenatal exposure to infection in the causation of schizophrenia.

Clarke MC; Tanskanen A; Huttunen M; Whittaker JC; Cannon M
Published paper: ENVIRONMENTAL SCIENCE & POLICY. 2003;6(3):301-309

Selecting forest reserves with a multiobjective spatial algorithm

Siitonen P; Tanskanen A; Lehtinen A
Published paper: SCHIZOPHRENIA RESEARCH. 2002;54(1-2):7-16

Adult schizotypal personality characteristics and prenatal influenza in a Finnish birth cohort.

Machón RA; Huttunen MO; Mednick SA; Sinivuo J; Tanskanen A; Bunn Watson J; Henriksson M; Pyhälä R
Published paper: ARCHIVES OF GENERAL PSYCHIATRY. 1999;56(8):733-740

Decline in the incidence of schizophrenia in Finnish cohorts born from 1954 to 1965.

Suvisaari JM; Haukka JK; Tanskanen AJ; Lönnqvist JK

Employments

Research Specialist, Department of Clinical Neuroscience, Karolinska Institutet, 2021-2025
Research Specialist, Department of Clinical Neuroscience, Karolinska Institutet, 2024-2024

Articles

All other publications

Employments

News from KI

Events from KI